Congenital nephrogenic diabetes insipidus treated with acetazolamide
Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13‐year‐old male known with CNDI who e...
Gespeichert in:
| Veröffentlicht in: | Nephrology (Carlton, Vic.) Vic.), 2024-07, Vol.29 (7), p.438-441 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 441 |
|---|---|
| container_issue | 7 |
| container_start_page | 438 |
| container_title | Nephrology (Carlton, Vic.) |
| container_volume | 29 |
| creator | Du Plessis, Wesley Chothia, Mogamat‐Yazied |
| description | Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13‐year‐old male known with CNDI who experienced a pedestrian vehicle accident leading to coma following a head injury. Intra‐operatively, severe hypernatraemia and polyuria were observed. Following an inadequate response to conventional therapy, acetazolamide was prescribed resulting in an immediate response to therapy. To the best of our knowledge, acetazolamide has not been previously documented as a therapeutic option for CNDI. Additional research is necessary before considering the recommendation of acetazolamide for cases of NDI that do not respond adequately to conventional treatments. |
| doi_str_mv | 10.1111/nep.14291 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2942186806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3071321685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3481-41b385148d29552be98c4f871671ea09bf0ca02eb7c835350567a2f4df4338393</originalsourceid><addsrcrecordid>eNp1kMtKw0AUQAdRbK0u_AEJuNFF2nklmSyl1gcUdaHrYTK5sVPyciah1K93aqoLwbuZO3A4XA5C5wRPiZ9ZDe2UcJqSAzQmnOOQJGly6HdGcRixSIzQiXNrjElCY3KMRkzwCKeYjdHtvKnfoTadKgOvWdlm99NBblQGHbjA1M60Ju9d0FlQHeTBxnSrQGno1GdTqsrkcIqOClU6ONu_E_R2t3idP4TL5_vH-c0y1IwLEnKSMRERLnKaRhHNIBWaFyIhcUJA4TQrsFaYQpZowfzZOIoTRQueF5wxwVI2QVeDt7XNRw-uk5VxGspS1dD0TtKUUyJigWOPXv5B101va3-dZDjxYUgsIk9dD5S2jXMWCtlaUym7lQTLXVrpm8jvtJ692Bv7rIL8l_xp6YHZAGxMCdv_TfJp8TIovwBkn4EH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3071321685</pqid></control><display><type>article</type><title>Congenital nephrogenic diabetes insipidus treated with acetazolamide</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Du Plessis, Wesley ; Chothia, Mogamat‐Yazied</creator><creatorcontrib>Du Plessis, Wesley ; Chothia, Mogamat‐Yazied</creatorcontrib><description>Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13‐year‐old male known with CNDI who experienced a pedestrian vehicle accident leading to coma following a head injury. Intra‐operatively, severe hypernatraemia and polyuria were observed. Following an inadequate response to conventional therapy, acetazolamide was prescribed resulting in an immediate response to therapy. To the best of our knowledge, acetazolamide has not been previously documented as a therapeutic option for CNDI. Additional research is necessary before considering the recommendation of acetazolamide for cases of NDI that do not respond adequately to conventional treatments.</description><identifier>ISSN: 1320-5358</identifier><identifier>ISSN: 1440-1797</identifier><identifier>EISSN: 1440-1797</identifier><identifier>DOI: 10.1111/nep.14291</identifier><identifier>PMID: 38450903</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Acetazolamide ; Acetazolamide - therapeutic use ; Adolescent ; Antidiuretics ; congenital ; Diabetes insipidus ; Diabetes Insipidus, Nephrogenic - diagnosis ; Diabetes Insipidus, Nephrogenic - drug therapy ; Humans ; Male ; nephrogenic ; Polyuria ; Treatment Outcome</subject><ispartof>Nephrology (Carlton, Vic.), 2024-07, Vol.29 (7), p.438-441</ispartof><rights>2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.</rights><rights>2024 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3481-41b385148d29552be98c4f871671ea09bf0ca02eb7c835350567a2f4df4338393</cites><orcidid>0009-0007-2824-0646 ; 0000-0002-9801-1300</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fnep.14291$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fnep.14291$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38450903$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Du Plessis, Wesley</creatorcontrib><creatorcontrib>Chothia, Mogamat‐Yazied</creatorcontrib><title>Congenital nephrogenic diabetes insipidus treated with acetazolamide</title><title>Nephrology (Carlton, Vic.)</title><addtitle>Nephrology (Carlton)</addtitle><description>Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13‐year‐old male known with CNDI who experienced a pedestrian vehicle accident leading to coma following a head injury. Intra‐operatively, severe hypernatraemia and polyuria were observed. Following an inadequate response to conventional therapy, acetazolamide was prescribed resulting in an immediate response to therapy. To the best of our knowledge, acetazolamide has not been previously documented as a therapeutic option for CNDI. Additional research is necessary before considering the recommendation of acetazolamide for cases of NDI that do not respond adequately to conventional treatments.</description><subject>Acetazolamide</subject><subject>Acetazolamide - therapeutic use</subject><subject>Adolescent</subject><subject>Antidiuretics</subject><subject>congenital</subject><subject>Diabetes insipidus</subject><subject>Diabetes Insipidus, Nephrogenic - diagnosis</subject><subject>Diabetes Insipidus, Nephrogenic - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>nephrogenic</subject><subject>Polyuria</subject><subject>Treatment Outcome</subject><issn>1320-5358</issn><issn>1440-1797</issn><issn>1440-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kMtKw0AUQAdRbK0u_AEJuNFF2nklmSyl1gcUdaHrYTK5sVPyciah1K93aqoLwbuZO3A4XA5C5wRPiZ9ZDe2UcJqSAzQmnOOQJGly6HdGcRixSIzQiXNrjElCY3KMRkzwCKeYjdHtvKnfoTadKgOvWdlm99NBblQGHbjA1M60Ju9d0FlQHeTBxnSrQGno1GdTqsrkcIqOClU6ONu_E_R2t3idP4TL5_vH-c0y1IwLEnKSMRERLnKaRhHNIBWaFyIhcUJA4TQrsFaYQpZowfzZOIoTRQueF5wxwVI2QVeDt7XNRw-uk5VxGspS1dD0TtKUUyJigWOPXv5B101va3-dZDjxYUgsIk9dD5S2jXMWCtlaUym7lQTLXVrpm8jvtJ692Bv7rIL8l_xp6YHZAGxMCdv_TfJp8TIovwBkn4EH</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Du Plessis, Wesley</creator><creator>Chothia, Mogamat‐Yazied</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0007-2824-0646</orcidid><orcidid>https://orcid.org/0000-0002-9801-1300</orcidid></search><sort><creationdate>202407</creationdate><title>Congenital nephrogenic diabetes insipidus treated with acetazolamide</title><author>Du Plessis, Wesley ; Chothia, Mogamat‐Yazied</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3481-41b385148d29552be98c4f871671ea09bf0ca02eb7c835350567a2f4df4338393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acetazolamide</topic><topic>Acetazolamide - therapeutic use</topic><topic>Adolescent</topic><topic>Antidiuretics</topic><topic>congenital</topic><topic>Diabetes insipidus</topic><topic>Diabetes Insipidus, Nephrogenic - diagnosis</topic><topic>Diabetes Insipidus, Nephrogenic - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>nephrogenic</topic><topic>Polyuria</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Du Plessis, Wesley</creatorcontrib><creatorcontrib>Chothia, Mogamat‐Yazied</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Du Plessis, Wesley</au><au>Chothia, Mogamat‐Yazied</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital nephrogenic diabetes insipidus treated with acetazolamide</atitle><jtitle>Nephrology (Carlton, Vic.)</jtitle><addtitle>Nephrology (Carlton)</addtitle><date>2024-07</date><risdate>2024</risdate><volume>29</volume><issue>7</issue><spage>438</spage><epage>441</epage><pages>438-441</pages><issn>1320-5358</issn><issn>1440-1797</issn><eissn>1440-1797</eissn><abstract>Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13‐year‐old male known with CNDI who experienced a pedestrian vehicle accident leading to coma following a head injury. Intra‐operatively, severe hypernatraemia and polyuria were observed. Following an inadequate response to conventional therapy, acetazolamide was prescribed resulting in an immediate response to therapy. To the best of our knowledge, acetazolamide has not been previously documented as a therapeutic option for CNDI. Additional research is necessary before considering the recommendation of acetazolamide for cases of NDI that do not respond adequately to conventional treatments.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>38450903</pmid><doi>10.1111/nep.14291</doi><tpages>4</tpages><orcidid>https://orcid.org/0009-0007-2824-0646</orcidid><orcidid>https://orcid.org/0000-0002-9801-1300</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1320-5358 |
| ispartof | Nephrology (Carlton, Vic.), 2024-07, Vol.29 (7), p.438-441 |
| issn | 1320-5358 1440-1797 1440-1797 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2942186806 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Acetazolamide Acetazolamide - therapeutic use Adolescent Antidiuretics congenital Diabetes insipidus Diabetes Insipidus, Nephrogenic - diagnosis Diabetes Insipidus, Nephrogenic - drug therapy Humans Male nephrogenic Polyuria Treatment Outcome |
| title | Congenital nephrogenic diabetes insipidus treated with acetazolamide |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A01%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20nephrogenic%20diabetes%20insipidus%20treated%20with%20acetazolamide&rft.jtitle=Nephrology%20(Carlton,%20Vic.)&rft.au=Du%20Plessis,%20Wesley&rft.date=2024-07&rft.volume=29&rft.issue=7&rft.spage=438&rft.epage=441&rft.pages=438-441&rft.issn=1320-5358&rft.eissn=1440-1797&rft_id=info:doi/10.1111/nep.14291&rft_dat=%3Cproquest_cross%3E3071321685%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3071321685&rft_id=info:pmid/38450903&rfr_iscdi=true |